Massachusetts Biomedical Initiatives
Overview
Massachusetts Biomedical Initiatives is a non-profit life sciences startup incubator and economic development organization that supports early-stage companies through facility access, workforce development, and regional innovation initiatives in Central Massachusetts.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Eascra Biotech | Jul 2025 | Accelerator | Co-investor |
| AAVINUE | Dec 2023 | Accelerator | Co-investor |
| Targeted Bioscience | Sep 2025 | Accelerator | Co-investor |
| XTOP Biotherapeutics Inc. | Apr 2025 | Accelerator | Co-investor |
| MedTherapy Biotech | - | Accelerator | Lead |
For institutional investors. Book with your work email.
Key People
Jon Weaver
President & CEO
Zu Shen
Vice President
Chris Palatucci
Board Director
Marsha Rolle
Director, Advancement
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Massachusetts Biomedical Initiatives based?
Massachusetts Biomedical Initiatives is headquartered in Worcester, Massachusetts, United States.
When was Massachusetts Biomedical Initiatives founded?
Massachusetts Biomedical Initiatives was founded in 1984.
How many portfolio companies does Massachusetts Biomedical Initiatives have?
Massachusetts Biomedical Initiatives has 22 portfolio companies in Caplight's dataset.
What are some companies in Massachusetts Biomedical Initiatives's portfolio?
Portfolio companies visible on Caplight include Eascra Biotech, AAVINUE, Targeted Bioscience, XTOP Biotherapeutics Inc., MedTherapy Biotech.
What was Massachusetts Biomedical Initiatives's most recent investment shown here?
Massachusetts Biomedical Initiatives's most recent investment in this portfolio sample was in Targeted Bioscience in 2025.
What sectors does Massachusetts Biomedical Initiatives focus on?
Massachusetts Biomedical Initiatives focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Massachusetts Biomedical Initiatives focus on?
Massachusetts Biomedical Initiatives typically invests at the Early stage.
What is Massachusetts Biomedical Initiatives's AUM?
Massachusetts Biomedical Initiatives's assets under management are estimated between $0.0 and $50.0M.